7170-44-7

Basic information

• Product Name: 11-PHENOXYUNDECANOIC ACID
• Synonyms: 11-PHENOXYUNDECANOIC ACID;11-Phenoxyundecanoic acid,99%
• CAS NO: 7170-44-7
• Molecular Formula: C₁₇H₂₆O₃
• Molecular Weight: 278.39
• EINECS: 230-520-5
• Product Categories: C13 to C42+;Carbonyl Compounds;Carboxylic Acids
• Mol File: 7170-44-7.mol
• Article Data: 4

Chemical Properties

• Melting Point: 77-78 °C(lit.)
• Boiling Point: 217-222 °C3 mm Hg(lit.)
• Flash Point: 146.4 °C
• Appearance: /
• Density: 1.0352 (rough estimate)
• Vapor Pressure: 2.91E-07mmHg at 25°C
• Refractive Index: 1.5490 (estimate)
• Solubility: chloroform: soluble25mg/mL, clear (Colorless to orange)
• CAS DataBase Reference: 11-PHENOXYUNDECANOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 11-PHENOXYUNDECANOIC ACID(7170-44-7)
• EPA Substance Registry System: 11-PHENOXYUNDECANOIC ACID(7170-44-7)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 7170-44-7(Hazardous Substances Data)

Usage

Uses

11-Phenoxyundecanoic Acid can be used to treat tuberculosis.

InChI:InChI=1/C17H26O3/c18-17(19)14-10-5-3-1-2-4-6-11-15-20-16-12-8-7-9-13-16/h7-9,12-13H,1-6,10-11,14-15H2,(H,18,19)/p-1

Upstream product

• 108-95-2 phenol 
• 6271-23-4 11-bromoundecanoic acid ethyl ester 
• 100-67-4 potassium phenolate 
• 1860-44-2 11-chloroundecanoic acid 
• 2834-05-1 11-bromoundecanoic acid 
• 52176-62-2 (9-bromo-nonyl)-phenyl ether 
• 105-53-3 diethyl malonate 

Downstream Products

• 1332746-56-1 C₄₄H₇₀N₂O₁₃ 
• 1235489-87-8 C₂₈H₄₉N₂O₉P 
• 492462-83-6 1,1,1-trifluoro-12-phenoxydodecan-2-one 
• 19097-15-5 11-phenoxy-1-undecanol 
• 125070-46-4 N-(2,2-diethoxyethyl)-11-phenoxyundecanamine, hydrochloride 

Relevant articles and documents

4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES

This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula wherein A1, A2, R1, m and n are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds inhibit carnitine palmitoyl transferase (CPT) activity, in particular CPT2 activity, and can be used as medicaments in methods for the treatment of diseases modulated by CPT2 inhibitors.

Modulation of vesicular properties by variation of shapes of bolaform counter ions in hybrid-ion paired surfactants

Four new vesicle-forming bolaphile/amphiphile ion pairs are synthesized; the bolaphile shapes in such hybrid systems strongly control their vesicular properties.